tnb-383b
abbvie
['tnb-383b', '$abbv']
$harp #ash22 winner +140%
higher doses of bispecific pn217 (bcmaxcd3) qw looks good with orr 77% (10/13). it looks similar to tnb-383b q3w from teneoone which $abbv licensed in june 2021 with orr 79% (19/24).
abbv has rights to pn217, but unlikely to exercise.